Previous Article | Next Article ![]()
Journal of Virology, May 2007, p. 4625-4632, Vol. 81, No. 9
0022-538X/07/$08.00+0 doi:10.1128/JVI.02160-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Anke Rosemann,
and
Dieter Blaas*
Max F. Perutz Laboratories, Department of Medical Biochemistry, Medical University of Vienna, A-1030 Vienna, Austria
Received 3 October 2006/ Accepted 1 February 2007
K-type major-group human rhinoviruses (HRVs) (including HRV54) share a prominent lysine residue in the HI surface loop of VP1 with all minor-group HRVs. Despite the presence of this residue, they cannot use members of the low-density lipoprotein receptor family for productive infection. Reexamining all K-type viruses for receptor usage, we noticed that HRV54 is able to replicate in RD cells that lack the major-group receptor intercellular adhesion molecule 1 (ICAM-1). By using receptor blocking assays, inhibition of sulfation, enzymatic digestion, and proteoglycan-deficient cell lines, we show here that wild-type HRV54, without any adaptation, uses heparan sulfate (HS) proteoglycan as an alternate receptor. However, infection via HS is less efficient than infection via ICAM-1. Moreover, HRV54 has an acid lability profile similar to that of the minor-group virus HRV2. In ICAM-1-deficient cells its replication is completely blocked by the H+-ATPase inhibitor bafilomycin A1, whereas in ICAM-1-expressing cells it replicates in the presence of the drug. Thus, use of a "noncatalytic" receptor requires the virus to be highly unstable at low pH.
Published ahead of print on 14 February 2007.
Present address: University of Natural Resources and Applied Life Sciences, Dept. Biotechnology, Institute of Applied Microbiology, Muthgasse 18, A-1190 Vienna, Austria.
Present address: Euroimmun AG, D-23560 Lübeck, Germany.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»